Table 5. Univariate and Multivariate analysis for proximal PSMs.
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Age | 0.99 | 0.955–1.026 | 0.568 | ||||
| BMI | 0.979 | 0.894–1.072 | 0.644 | ||||
| PSA | 1.651 | 0.992–2.749 | 0.054 | 1.436 | 0.847–2.433 | 0.179 | |
| NLR | 1.018 | 0.870–1.191 | 0.826 | ||||
| PLR | 0.999 | 0.994–1.003 | 0.556 | ||||
| LMR | 1.084 | 0.965–1.218 | 0.173 | ||||
| Prognostic nutritional index | 0.995 | 0.950–1.043 | 0.846 | ||||
| Biopsy Gleason sum (≥8 vs. <8) | 1.414 | 0.852–2.346 | 0.181 | ||||
| Perineural invasion | 0.86 | 0.502–1.474 | 0.584 | ||||
| SVI | 2.413 | 1.373–4.240 | 0.002* | 2.052 | 1.124–3.746 | 0.019* | |
| Pathologic Gleason sum (≥8 vs. <8) | 1.765 | 1.058–2.945 | 0.03* | 1.329 | 0.762–2.317 | 0.316 | |
*, statistically significant. BMI, body mass index; PSA, prostate specific antigen; NLR, neutrophil to lymphocyte ratio; PLR, platelets to lymphocyte ratio; LMR, lymphocyteto monocyte ratio; SVI, seminal vesicle invasion.